Interest in private markets varies sharply by age. Members of Gen Z and Millennials are far more open to investing in private ...
Zimmer Biomet is undervalued despite recent underperformance, backed by innovation, acquisitions, and strong cash flow. Learn ...
Sanofi recently announced that its investigational radiopharmaceutical therapy, AlphaMedix™, met all primary efficacy endpoints in a Phase II trial for patients with unresectable or metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback